Methods of producing adalimumab

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9284371
APP PUB NO 20160039927A1
SERIAL NO

14920452

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention describes improved methods and compositions for producing a recombinant protein, e.g., an antibody, in mammalian cell culture. In addition, the invention provides improved cell culture media, including improved production media, feed solutions, and combination feeds, which may be used to improve protein productivity in mammalian cell culture.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ABBVIE INCONE NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bruton, David F Enfield, US 13 770
Chang, Yu-Hsiang D Solana Beach, US 7 101
Fann, John C Shrewsbury, US 15 775
Matuck, Joseph G Worcester, US 16 577
McIntire, James Castro Valley, US 14 778
Pla, Itzcoatl A Worcester, US 13 770
Roy, Nichole A Worcester, US 12 659
Schulz, Christof Ayer, US 19 894
Seewoester, Thomas Simi Valley, US 14 771

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 15, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00